ClinicalTrials.gg
CompletedNCT06976580Updated Oct 13, 2026

Effect of Skin Stretching on Pain Reduction During Local Anesthetic Injections: A Randomized Clinical Study

An interventional study of conventional local anesthetic injection and skin stetching technique for local anesthetic injection in Lumbar Spinal Stenosis With Bilateral Lower Extremity Radiculopathy, sponsored by Yonsei University. Completed at 1 site in South Korea. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Yonsei University · Not applicable, Interventional, and Prevention

How we know

Updated Sep 30, 2026Now CompletedFirst site in South Korea+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
104
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 37 studies in Spinal Stenosis with a site in Korea, Republic of — 5 open to participants now, 6 under way, none of them phase 3. Spinal Stenosis · Korea, Republic of.

Enrollment
7th of 26
104 · median 59
Started
2025
the only one that year
No phase
21 of 37
2 open now
Registered
33rd of 37
by date
Lead sponsor
8 of 37
Yonsei University

Among the 37 studies in Spinal Stenosis with a site in Korea, Republic of, this one is the 7th largest by enrollment of the 26 interventional ones that give a count, is the only one that started in 2025, is one of 21 with no phase, and was the 33rd registered.

Spinal Stenosis

460 studies on the registry are indexed under Spinal Stenosis; 107 are open to participants now.

Browse Spinal Stenosis studies →

Open to participants now

5 of the 37 studies in Spinal Stenosis with a site in Korea, Republic of are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →

Who these studies take

Of the 66 Spinal Stenosis studies recruiting now, 30 (45%) set no upper age limit and 9 (14%) stop at 75 or younger; 2 take children under 18; 6 take healthy volunteers.

This study: 19 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 37 studies in Spinal Stenosis with a site in Korea, Republic of, or all of them as a file.
02

Study summary

The purpose of this study is to investigate the potential analgesic effect of skin stretching during local anesthetic injection in patients with chronic lumbar pain and bilateral lower extremity radiculopathy undergoing selective transforaminal nerve block. This research is based on the hypothesis that mechanical skin stretching can reduce injection-related pain by facilitating the dispersion of the anesthetic agent and decreasing tissue resistance. By comparing the skin stretching technique with the conventional method of local anesthetic administration, this study aims to evaluate differences in pain perception, discomfort, and behavioral pain responses. The ultimate goal is to provide evidence for a simple, non-invasive, and effective intervention that can improve patient comfort and enhance the quality of clinical pain management.

03

Conditions studied

  • Lumbar Spinal Stenosis With Bilateral Lower Extremity Radiculopathy

Browse trials for

Keywords

  • skin stretching
  • local anesthetic injection pain
  • lumbar spinal stenosis
04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 19 years or older with chronic low back pain lasting for more than 3 months, accompanied by bilateral lower extremity radiculopathy, who require Selective Transforaminal Epidural Block (STEB).
  • Patients with a Numerical Rating Scale (NRS) score of 5/10 or higher, with pain that affects daily life activities.

Exclusion criteria

Exclusion Criteria:

  • Patients whose pain is influenced by mechanisms other than radiculopathy, such as peripheral neuropathy or myelopathy.
  • Patients with a history of lumbar surgery within the last 6 months, or spinal injection treatment within the last 3 months.
  • Patients with a history of allergy to local anesthetics, , or contrast agents, or those at increased bleeding risk due to anticoagulant use ( > 1.2).
  • Patients with localized infections, sepsis, uncontrolled diabetes, or hypertension.
  • Patients who are unable to consent or cooperate with the study procedures (e.g., cognitive impairment, severe mental illness).
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

INR, PT and aPTT (clotting tests)

Blood tests of how long blood takes to clot. The INR is the prothrombin time (PT) put on a common scale; about 1 is usual for someone not taking a blood thinner.

Criteria often make an exception for people on a blood thinner such as warfarin, whose INR is raised on purpose.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
104 participants (actual)

Study arms

  • Experimental
    control group

    conventional local anesthetic group

    Procedure: conventional local anesthetic injection

  • Active comparator
    skin stretching group

    skin stretching group for anesthetic local injection

    Procedure: skin stetching technique for local anesthetic injection

Interventions

  • Procedureconventional local anesthetic injection

    A conventional infiltration anesthesia will be conducted on the lumbar area of the patient, targeting the epidermis and subcutaneous tissue. A 25G syringe will be used, with the needle angle set between 30° and 45°. 1cc of 1% lidocaine will be injected. The target size of the wheal is 5-10 mm.

  • Procedureskin stetching technique for local anesthetic injection

    Skin stretching techinique will be applied to the local anesthetic injection site by stretching the skin around the needle entry point.

06

What researchers measure

Primary outcomes

  1. Pain score

    A comparison of pain score between control (conventional local anesthetic method) and skin stretching group using NRS.

    Time frame: immediately after the local injection

Secondary outcomes

  1. unpleasantness score

    A comparison of unplesantness score(NRS), and skin stretching group.

    Time frame: immediately after for unpleasantness score, behavior pain score, and 1 month after for soreness, respectively.

  2. behavior pain score

    pain behavior using Pain Assessment in Advanced Dementia (PAINAD) scale, and skin stretching group.

    Time frame: immediately after for unpleasantness score, behavior pain score, and 1 month after for soreness, respectively.

  3. soreness around the injection site

    soreness around the injection site between control (conventional local anesthetic method) and skin stretching group using NRS (numeral rating scale).

    Time frame: immediately after for unpleasantness score, behavior pain score, and 1 month after for soreness, respectively.

07

Study locations

1 site
  • Yonsei University College of Medicine
    Seoul, Seodamun-gu, South Korea
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2025 to primary completion in Jan 2026, 8 months.

Of 106 non-industry interventional studies with no phase under Spinal Stenosis, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 46. This study's 8 months is below that.

Counting every sponsor, half of 124 studies reached it within 30 months; a quarter within 12 and three quarters within 50.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 30, 2026: primary completion Dec 2025 → Jan 2026 and completion Dec 2025 → Jan 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 21, 2025
First posted
May 16, 2025
StartActual
May 7, 2025
Primary completionActual
Jan 26, 2026was Dec 2025
CompletionActual
Jan 26, 2026was Dec 2025
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Sep 30, 2026
Sites
1 site added — first site in South Korea
Show site
  • Yonsei University College of Medicine · Seoul, South Korea
Sep 30, 2026
Primary completion
Dec 31, 2025→Jan 26, 2026 (actual)
Sep 30, 2026
Study completion
Dec 31, 2025→Jan 26, 2026 (actual)
Sep 30, 2026
Show all 2 updates
  1. Oct 13, 2026
    Minor edits only
    + 1 other change: verification date
  2. Sep 30, 2026
    Not yet recruiting→Completed
    1 site added — first site in South Korea
    Show site
    • Yonsei University College of Medicine · Seoul, South Korea
    Primary completion Dec 31, 2025→Jan 26, 2026 (now actual)
    Study completion Dec 31, 2025→Jan 26, 2026 (now actual)
    + 3 other changes: index terms, verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06976580
Lead sponsor
Yonsei University
Responsible party
Sponsor
First posted
May 16, 2025
Start date
May 7, 2025
Primary completion
Jan 26, 2026
Completion
Jan 26, 2026
Last update
Oct 13, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion